Amendment No. 1 to Sales AgreementsSales Agreements • March 30th, 2018 • Ultragenyx Pharmaceutical Inc. • Pharmaceutical preparations • New York
This Amendment No. 1 to Sales Agreement, dated March 30, 2018 (the “Amendment”), is entered into by and between Ultragenyx Pharmaceutical Inc. (the “Company”) and Cowen and Company, LLC (“Cowen”), and amends that certain Sales Agreement, dated July 27, 2017 (the “Sales Agreement”), by and between the Company and Cowen. Capitalized terms used but not defined herein shall have the meaning ascribed to them in the Sales Agreement.
